Skip to main content
Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Understanding metabolic alterations after SARS-CoV-2 infection: insights from the patients’ oral microenvironmental metabolites

Fig. 4

Metabolic pathways in COVID-19, especially tyrosine-related metabolism pathway. A Metabolic topological analysis diagram of COVID-19 metabolomics. B The box plots of L-glutamic acid, proline and leucylproline in control, influenza and COVID-19. Green: Control subjects, blue: Influenza subjects, red: COVID-19 subjects. C The interactive network of tyrosine-related metabolic pathways. D The box plots of 4-hydroxyphenylpyruvic acid, dopamine, epinephrine, and 3-methoxytyramine in control, influenza and COVID-19. Green: Control subjects, blue: Influenza subjects, red: COVID-19 subjects. *p < 0.05, **p < 0.01, *** p < 0.0001

Back to article page